0001209191-14-059774.txt : 20140925 0001209191-14-059774.hdr.sgml : 20140925 20140925162301 ACCESSION NUMBER: 0001209191-14-059774 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20140923 FILED AS OF DATE: 20140925 DATE AS OF CHANGE: 20140925 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: TETRAPHASE PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001373707 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 480 ARSENAL STREET STREET 2: SUITE 110 CITY: WATERTOWN STATE: MA ZIP: 02472 BUSINESS PHONE: 617.715.3600 MAIL ADDRESS: STREET 1: 480 ARSENAL STREET STREET 2: SUITE 110 CITY: WATERTOWN STATE: MA ZIP: 02472 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Macdonald Guy CENTRAL INDEX KEY: 0001296998 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35837 FILM NUMBER: 141120860 MAIL ADDRESS: STREET 1: C/O IDENIX PHARMACEUTICALS, INC. STREET 2: 60 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2014-09-23 0 0001373707 TETRAPHASE PHARMACEUTICALS INC TTPH 0001296998 Macdonald Guy 480 ARSENAL ST. SUITE 110 WATERTOWN MA 02472 1 1 0 0 President and Chief Executive Common Stock 2014-09-23 4 M 0 9641 2.03 A 59641 D Common Stock 2014-09-23 4 M 0 359 2.03 A 60000 D Common Stock 2014-09-23 4 S 0 10000 18.466 D 50000 D Employee Stock Option (right to buy) 2.03 2014-09-23 4 M 0 9641 0.00 D 2020-09-27 Common Stock 9641 79361 D Employee Stock Option (right to buy) 2.03 2014-09-23 4 M 0 359 0.00 D 2022-06-05 Common Stock 359 12534 D The exercise and sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 9, 2013. The price reported represents the weighted average sales price of shares sold in multiple transactions at prices ranging from $18.00 to $18.78 per share. The reporting person hereby undertakes, upon request of the staff of the U.S. Securities and Exchange Commission, the issuer, or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Fully vested. This option was granted on June 6, 2012 with respect to 12,893 shares of Common Stock, with 6.25% vesting at the end of each successive three month period until June 6, 2016. /s/ David C. Lubner (as attorney-in-fact for Guy Macdonald) 2014-09-25